Literature DB >> 33079980

Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia.

Jonathan B Parr1.   

Abstract

Entities:  

Year:  2021        PMID： 33079980     DOI： 10.1001/jamainternmed.2020.6557

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  21 in total

1.  Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.

Authors:  María Ángeles Rodríguez-Hernández; David Carneros; María Núñez-Núñez; Ramón Coca; Rosario Baena; Gema M López-Ruiz; María Elena Cano-Serrano; Alberto Martínez-Tellería; Ana Fuentes-López; Juan Manuel Praena-Fernandez; Christoph Garbers; José Hernández-Quero; Federico García; Stefan Rose-John; Matilde Bustos
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

Review 2.  Cytokine storms, evolution and COVID-19.

Authors:  Joe Alcock; Alix Masters
Journal:  Evol Med Public Health       Date:  2021-02-04

3.  Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).

Authors:  Matteo Bassetti; Daniele Roberto Giacobbe; Paolo Bruzzi; Emanuela Barisione; Stefano Centanni; Nadia Castaldo; Silvia Corcione; Francesco Giuseppe De Rosa; Fabiano Di Marco; Andrea Gori; Andrea Gramegna; Guido Granata; Angelo Gratarola; Alberto Enrico Maraolo; Malgorzata Mikulska; Andrea Lombardi; Federico Pea; Nicola Petrosillo; Dejan Radovanovic; Pierachille Santus; Alessio Signori; Emanuela Sozio; Elena Tagliabue; Carlo Tascini; Carlo Vancheri; Antonio Vena; Pierluigi Viale; Francesco Blasi
Journal:  Infect Dis Ther       Date:  2021-07-30

4.  Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model.

Authors:  Vivek V Thacker; Kunal Sharma; Neeraj Dhar; Gian-Filippo Mancini; Jessica Sordet-Dessimoz; John D McKinney
Journal:  EMBO Rep       Date:  2021-05-27       Impact factor: 8.807

Review 5.  Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2.

Authors:  Nima Taefehshokr; Sina Taefehshokr; Bryan Heit
Journal:  Pathogens       Date:  2020-12-08

6.  Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020.

Authors:  Sameer S Kadri; Cumhur Y Demirkale; Junfeng Sun; Lindsay M Busch; Jeffrey R Strich; Ning Rosenthal; Sarah Warner
Journal:  Open Forum Infect Dis       Date:  2020-12-15       Impact factor: 3.835

7.  Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment.

Authors:  Mina T Kelleni
Journal:  SN Compr Clin Med       Date:  2021-02-19

Review 8.  COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Authors:  Antonio Macciò; Sara Oppi; Clelia Madeddu
Journal:  J Ovarian Res       Date:  2021-02-08       Impact factor: 4.234

Review 9.  A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.

Authors:  Chris R Triggle; Devendra Bansal; Hong Ding; Md Mazharul Islam; Elmoubashar Abu Baker Abd Farag; Hamad Abdel Hadi; Ali A Sultan
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 10.  Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.

Authors:  Sandeep Satsangi; Nitin Gupta; Parul Kodan
Journal:  J Clin Transl Hepatol       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.